Chargement en cours...
Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs Fund
BACKGROUND: The NHS Cancer Drugs Fund (CDF) was established in 2010 to reduce delays and improve access to cancer drugs, including those that had been previously appraised but not approved by NICE (National Institute for Health and Care Excellence). After 1.3 billion GBP expenditure, a UK parliament...
Enregistré dans:
| Publié dans: | Ann Oncol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5834015/ https://ncbi.nlm.nih.gov/pubmed/28453615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx110 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|